Loading…
Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study
The objective of this study was to describe trends for the years 2004 to 2006 in the incidence of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae -producing extended-spectrum β-lactamase (ESBLE) in a large hospital network (70 hospitals in eastern France). The incidence of...
Saved in:
Published in: | European journal of clinical microbiology & infectious diseases 2008-11, Vol.27 (11), p.1113-1117 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33 |
---|---|
cites | cdi_FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33 |
container_end_page | 1117 |
container_issue | 11 |
container_start_page | 1113 |
container_title | European journal of clinical microbiology & infectious diseases |
container_volume | 27 |
creator | Bertrand, X. Mouchot, L. Jebabli, M. Bajolet, O. Aho, S. Blech, M.-F. Eloy, C. Floret, N. Gayet, S. Talon, D. Tronel, H. |
description | The objective of this study was to describe trends for the years 2004 to 2006 in the incidence of methicillin-resistant
Staphylococcus aureus
(MRSA) and
Enterobacteriaceae
-producing extended-spectrum β-lactamase (ESBLE) in a large hospital network (70 hospitals in eastern France). The incidence of MRSA per 1,000 patient-days decreased significantly from 0.55 in 2004 to 0.45 in 2006. This trend was observed in medicine and surgery units, whereas MRSA incidence was stable in intensive care, paediatric and obstetric units. The incidence of blood cultures positive for MRSA remained stable at 0.04 per 1,000 patient-days. Conversely, the incidence of ESBLE increased significantly from 0.04 in 2004 to 0.08 in 2006. This increase was caused by the spread of ESBLE-producing
Escherichia coli
. The mean consumption of alcohol-based gel and solution (ABS), expressed in litres per 1,000 patient-days, was 3.3 in 2002, 4.5 in 2003, 5.4 in 2004 and 6.4 in 2005. There was no association between the consumption of ABS and MRSA incidence. These findings suggest that the French recommendations for the control of multi-drug-resistant bacteria (MDRB) have been effective in reducing, or at least stabilising, the incidence of MRSA in an international context of general increase. However, the diffusion of ESBLE-producing
E. coli
is a matter of concern and should be carefully monitored. |
doi_str_mv | 10.1007/s10096-008-0536-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00341661v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>872125388</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33</originalsourceid><addsrcrecordid>eNp9ks9uEzEQxlcIRNPCA3BBPkFzMPjP7trLLVQpRQpCIuW8mtizjatdb7C9iLxW34AX4JlwlAhuvXis8e_7NBp_RfGKs3ecMfU-5rOpKWOaskrmy5NixktZ0VIq-bSYsUaWtFFCnhXnMd6zrNFKPS_OuC61FpWeFb9vA3obydiRAdPWGdf3ztOA0cUEPpF1gt12349mNGaKBKaAuVx--bZezAl4S5Y-YRg3YHJxYBCQ7sJoJ-P8HcFfKdujpXGHJoVpIH8eaJ9ZGCAiuVyuP66Wc-I8QYjZwJPrAN7gBwIkbQMi3SMEMkx9ctSgTwEzbJzFDJGYJrt_UTzroI_48lQviu_Xy9urG7r6-unz1WJFTcl0ymuQooEOOyMkZ7qxFoF1inHWgKo3kqtqA5tKlcA0VlYopSphhChtZ23XSXlRzI--W-jbXXADhH07gmtvFqv20GNMlryu-U-e2bdHNm_ix4QxtYOLBvsePI5TbLUSXFRS60y-eZSsG1UzJVQG-RE0YYwxYPdvBs7aQxraYxryGLo9pKFlWfP6ZD5tBrT_Fafvz4A4AjE_-TsM7f04BZ_X-IjrX7sbwyg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69760727</pqid></control><display><type>article</type><title>Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study</title><source>Springer Nature</source><creator>Bertrand, X. ; Mouchot, L. ; Jebabli, M. ; Bajolet, O. ; Aho, S. ; Blech, M.-F. ; Eloy, C. ; Floret, N. ; Gayet, S. ; Talon, D. ; Tronel, H.</creator><creatorcontrib>Bertrand, X. ; Mouchot, L. ; Jebabli, M. ; Bajolet, O. ; Aho, S. ; Blech, M.-F. ; Eloy, C. ; Floret, N. ; Gayet, S. ; Talon, D. ; Tronel, H.</creatorcontrib><description>The objective of this study was to describe trends for the years 2004 to 2006 in the incidence of methicillin-resistant
Staphylococcus aureus
(MRSA) and
Enterobacteriaceae
-producing extended-spectrum β-lactamase (ESBLE) in a large hospital network (70 hospitals in eastern France). The incidence of MRSA per 1,000 patient-days decreased significantly from 0.55 in 2004 to 0.45 in 2006. This trend was observed in medicine and surgery units, whereas MRSA incidence was stable in intensive care, paediatric and obstetric units. The incidence of blood cultures positive for MRSA remained stable at 0.04 per 1,000 patient-days. Conversely, the incidence of ESBLE increased significantly from 0.04 in 2004 to 0.08 in 2006. This increase was caused by the spread of ESBLE-producing
Escherichia coli
. The mean consumption of alcohol-based gel and solution (ABS), expressed in litres per 1,000 patient-days, was 3.3 in 2002, 4.5 in 2003, 5.4 in 2004 and 6.4 in 2005. There was no association between the consumption of ABS and MRSA incidence. These findings suggest that the French recommendations for the control of multi-drug-resistant bacteria (MDRB) have been effective in reducing, or at least stabilising, the incidence of MRSA in an international context of general increase. However, the diffusion of ESBLE-producing
E. coli
is a matter of concern and should be carefully monitored.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-008-0536-0</identifier><identifier>PMID: 18488258</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>beta-Lactamases - biosynthesis ; Biomedical and Life Sciences ; Biomedicine ; Concise Article ; Enterobacteriaceae - enzymology ; Enterobacteriaceae - isolation & purification ; Enterobacteriaceae Infections - epidemiology ; Enterobacteriaceae Infections - microbiology ; Escherichia coli ; France - epidemiology ; Hand Disinfection - methods ; Hospitals ; Humans ; Incidence ; Infection Control - methods ; Internal Medicine ; Life Sciences ; Medical Microbiology ; Methicillin-Resistant Staphylococcus aureus - isolation & purification ; Microbiology and Parasitology ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - microbiology ; Staphylococcus aureus</subject><ispartof>European journal of clinical microbiology & infectious diseases, 2008-11, Vol.27 (11), p.1113-1117</ispartof><rights>Springer-Verlag 2008</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33</citedby><cites>FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33</cites><orcidid>0000-0003-4114-7263</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18488258$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00341661$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Bertrand, X.</creatorcontrib><creatorcontrib>Mouchot, L.</creatorcontrib><creatorcontrib>Jebabli, M.</creatorcontrib><creatorcontrib>Bajolet, O.</creatorcontrib><creatorcontrib>Aho, S.</creatorcontrib><creatorcontrib>Blech, M.-F.</creatorcontrib><creatorcontrib>Eloy, C.</creatorcontrib><creatorcontrib>Floret, N.</creatorcontrib><creatorcontrib>Gayet, S.</creatorcontrib><creatorcontrib>Talon, D.</creatorcontrib><creatorcontrib>Tronel, H.</creatorcontrib><title>Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study</title><title>European journal of clinical microbiology & infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>The objective of this study was to describe trends for the years 2004 to 2006 in the incidence of methicillin-resistant
Staphylococcus aureus
(MRSA) and
Enterobacteriaceae
-producing extended-spectrum β-lactamase (ESBLE) in a large hospital network (70 hospitals in eastern France). The incidence of MRSA per 1,000 patient-days decreased significantly from 0.55 in 2004 to 0.45 in 2006. This trend was observed in medicine and surgery units, whereas MRSA incidence was stable in intensive care, paediatric and obstetric units. The incidence of blood cultures positive for MRSA remained stable at 0.04 per 1,000 patient-days. Conversely, the incidence of ESBLE increased significantly from 0.04 in 2004 to 0.08 in 2006. This increase was caused by the spread of ESBLE-producing
Escherichia coli
. The mean consumption of alcohol-based gel and solution (ABS), expressed in litres per 1,000 patient-days, was 3.3 in 2002, 4.5 in 2003, 5.4 in 2004 and 6.4 in 2005. There was no association between the consumption of ABS and MRSA incidence. These findings suggest that the French recommendations for the control of multi-drug-resistant bacteria (MDRB) have been effective in reducing, or at least stabilising, the incidence of MRSA in an international context of general increase. However, the diffusion of ESBLE-producing
E. coli
is a matter of concern and should be carefully monitored.</description><subject>beta-Lactamases - biosynthesis</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Concise Article</subject><subject>Enterobacteriaceae - enzymology</subject><subject>Enterobacteriaceae - isolation & purification</subject><subject>Enterobacteriaceae Infections - epidemiology</subject><subject>Enterobacteriaceae Infections - microbiology</subject><subject>Escherichia coli</subject><subject>France - epidemiology</subject><subject>Hand Disinfection - methods</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infection Control - methods</subject><subject>Internal Medicine</subject><subject>Life Sciences</subject><subject>Medical Microbiology</subject><subject>Methicillin-Resistant Staphylococcus aureus - isolation & purification</subject><subject>Microbiology and Parasitology</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcus aureus</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9ks9uEzEQxlcIRNPCA3BBPkFzMPjP7trLLVQpRQpCIuW8mtizjatdb7C9iLxW34AX4JlwlAhuvXis8e_7NBp_RfGKs3ecMfU-5rOpKWOaskrmy5NixktZ0VIq-bSYsUaWtFFCnhXnMd6zrNFKPS_OuC61FpWeFb9vA3obydiRAdPWGdf3ztOA0cUEPpF1gt12349mNGaKBKaAuVx--bZezAl4S5Y-YRg3YHJxYBCQ7sJoJ-P8HcFfKdujpXGHJoVpIH8eaJ9ZGCAiuVyuP66Wc-I8QYjZwJPrAN7gBwIkbQMi3SMEMkx9ctSgTwEzbJzFDJGYJrt_UTzroI_48lQviu_Xy9urG7r6-unz1WJFTcl0ymuQooEOOyMkZ7qxFoF1inHWgKo3kqtqA5tKlcA0VlYopSphhChtZ23XSXlRzI--W-jbXXADhH07gmtvFqv20GNMlryu-U-e2bdHNm_ix4QxtYOLBvsePI5TbLUSXFRS60y-eZSsG1UzJVQG-RE0YYwxYPdvBs7aQxraYxryGLo9pKFlWfP6ZD5tBrT_Fafvz4A4AjE_-TsM7f04BZ_X-IjrX7sbwyg</recordid><startdate>20081101</startdate><enddate>20081101</enddate><creator>Bertrand, X.</creator><creator>Mouchot, L.</creator><creator>Jebabli, M.</creator><creator>Bajolet, O.</creator><creator>Aho, S.</creator><creator>Blech, M.-F.</creator><creator>Eloy, C.</creator><creator>Floret, N.</creator><creator>Gayet, S.</creator><creator>Talon, D.</creator><creator>Tronel, H.</creator><general>Springer-Verlag</general><general>Springer Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-4114-7263</orcidid></search><sort><creationdate>20081101</creationdate><title>Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study</title><author>Bertrand, X. ; Mouchot, L. ; Jebabli, M. ; Bajolet, O. ; Aho, S. ; Blech, M.-F. ; Eloy, C. ; Floret, N. ; Gayet, S. ; Talon, D. ; Tronel, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>beta-Lactamases - biosynthesis</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Concise Article</topic><topic>Enterobacteriaceae - enzymology</topic><topic>Enterobacteriaceae - isolation & purification</topic><topic>Enterobacteriaceae Infections - epidemiology</topic><topic>Enterobacteriaceae Infections - microbiology</topic><topic>Escherichia coli</topic><topic>France - epidemiology</topic><topic>Hand Disinfection - methods</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infection Control - methods</topic><topic>Internal Medicine</topic><topic>Life Sciences</topic><topic>Medical Microbiology</topic><topic>Methicillin-Resistant Staphylococcus aureus - isolation & purification</topic><topic>Microbiology and Parasitology</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcus aureus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bertrand, X.</creatorcontrib><creatorcontrib>Mouchot, L.</creatorcontrib><creatorcontrib>Jebabli, M.</creatorcontrib><creatorcontrib>Bajolet, O.</creatorcontrib><creatorcontrib>Aho, S.</creatorcontrib><creatorcontrib>Blech, M.-F.</creatorcontrib><creatorcontrib>Eloy, C.</creatorcontrib><creatorcontrib>Floret, N.</creatorcontrib><creatorcontrib>Gayet, S.</creatorcontrib><creatorcontrib>Talon, D.</creatorcontrib><creatorcontrib>Tronel, H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>European journal of clinical microbiology & infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bertrand, X.</au><au>Mouchot, L.</au><au>Jebabli, M.</au><au>Bajolet, O.</au><au>Aho, S.</au><au>Blech, M.-F.</au><au>Eloy, C.</au><au>Floret, N.</au><au>Gayet, S.</au><au>Talon, D.</au><au>Tronel, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study</atitle><jtitle>European journal of clinical microbiology & infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2008-11-01</date><risdate>2008</risdate><volume>27</volume><issue>11</issue><spage>1113</spage><epage>1117</epage><pages>1113-1117</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>The objective of this study was to describe trends for the years 2004 to 2006 in the incidence of methicillin-resistant
Staphylococcus aureus
(MRSA) and
Enterobacteriaceae
-producing extended-spectrum β-lactamase (ESBLE) in a large hospital network (70 hospitals in eastern France). The incidence of MRSA per 1,000 patient-days decreased significantly from 0.55 in 2004 to 0.45 in 2006. This trend was observed in medicine and surgery units, whereas MRSA incidence was stable in intensive care, paediatric and obstetric units. The incidence of blood cultures positive for MRSA remained stable at 0.04 per 1,000 patient-days. Conversely, the incidence of ESBLE increased significantly from 0.04 in 2004 to 0.08 in 2006. This increase was caused by the spread of ESBLE-producing
Escherichia coli
. The mean consumption of alcohol-based gel and solution (ABS), expressed in litres per 1,000 patient-days, was 3.3 in 2002, 4.5 in 2003, 5.4 in 2004 and 6.4 in 2005. There was no association between the consumption of ABS and MRSA incidence. These findings suggest that the French recommendations for the control of multi-drug-resistant bacteria (MDRB) have been effective in reducing, or at least stabilising, the incidence of MRSA in an international context of general increase. However, the diffusion of ESBLE-producing
E. coli
is a matter of concern and should be carefully monitored.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>18488258</pmid><doi>10.1007/s10096-008-0536-0</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-4114-7263</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0934-9723 |
ispartof | European journal of clinical microbiology & infectious diseases, 2008-11, Vol.27 (11), p.1113-1117 |
issn | 0934-9723 1435-4373 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_00341661v1 |
source | Springer Nature |
subjects | beta-Lactamases - biosynthesis Biomedical and Life Sciences Biomedicine Concise Article Enterobacteriaceae - enzymology Enterobacteriaceae - isolation & purification Enterobacteriaceae Infections - epidemiology Enterobacteriaceae Infections - microbiology Escherichia coli France - epidemiology Hand Disinfection - methods Hospitals Humans Incidence Infection Control - methods Internal Medicine Life Sciences Medical Microbiology Methicillin-Resistant Staphylococcus aureus - isolation & purification Microbiology and Parasitology Staphylococcal Infections - epidemiology Staphylococcal Infections - microbiology Staphylococcus aureus |
title | Trends of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A26%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20of%20methicillin-resistant%20Staphylococcus%20aureus%20(MRSA)%20and%20Enterobacteriaceae-producing%20extended-spectrum%20%CE%B2-lactamase%20(ESBLE)%20in%20eastern%20France:%20a%20three-year%20multi-centre%20incidence%20study&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Bertrand,%20X.&rft.date=2008-11-01&rft.volume=27&rft.issue=11&rft.spage=1113&rft.epage=1117&rft.pages=1113-1117&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-008-0536-0&rft_dat=%3Cproquest_hal_p%3E872125388%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-97329afefc231089ddea0f70109a76b3175bab574a08e5d277752c224dfddff33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69760727&rft_id=info:pmid/18488258&rfr_iscdi=true |